Towards this goal, in this study, we established resistance to EGFR inhibition in NSCLC cells and identified novel parallel mechanisms by which the transcription factor, grainyhead-like 2 (GRHL2), and E-cadherin drive drug resistance. Here, EGFR is linked to non-small cell lung carcinoma.